Low molecular weight fucoidan ameliorating the chronic cisplatin-induced delayed gastrointestinal motility in rats

Food and Chemical Toxicology

Volumn 50, Issue 12, 2012, Pages 4468-4478

  Song, Moon Yong ^a,d   Ku, Sae Kwang ^b   Kim, Hyun Jee ^c   Han, Jin Soo ^d  

^a Korea Institute of Construction Materials   (South Korea)

^b Daegu Haany University   (South Korea)

^c Keimyung University School of Medicine   (South Korea)

^d Konkuk University   (South Korea)

Author keywords

Chemotherapy; Cisplatin; Delayed gastrointestinal motility; Enterochromaffin cell; Low molecular weight fucoidan

Indexed keywords

CISPLATIN; FUCOIDIN; GASTRIN; ONDANSETRON; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENTEROCHROMAFFIN CELL; ENZYME ACTIVITY; GASTROINTESTINAL MOTILITY DISORDER; HISTOPATHOLOGY; MALE; MOLECULAR WEIGHT; NONHUMAN; RAT; SEROTONIN METABOLISM; WEIGHT GAIN;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CHRONIC DISEASE; CISPLATIN; ENTEROCHROMAFFIN CELLS; GASTROINTESTINAL MOTILITY; MALE; MOLECULAR WEIGHT; MONOAMINE OXIDASE; ONDANSETRON; POLYSACCHARIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN, 5-HT3; SEAWEED; SEROTONIN; SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS; TRYPTOPHAN HYDROXYLASE; UNDARIA;

RATTUS;

EID: 84867607903     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.09.020     Document Type: Article

References (72)

1. Aebi H. Catalase. Methods in Enzymatic Analysis 1974, 673-686. Academic Press, New York. H.U. Bergmeyer (Ed.).
2. Ali B.H., Al Moundhri M.S. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Food Chem. Toxicol. 2006, 44:1173-1183.
3. Beck T.M., Ciociola A.A., Jones S.E., Harvey W.H., Tchekmedyian N.S., Chang A., Galvin D., Hart N.E. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy. The ondansetron study group. Ann. Intern. Med. 1993, 118:407-413.
4. Berteau O., Mulloy B. Sulfated fucans, fresh perspectives: structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide. Glycobiology 2003, 13:29R-40R.
5. Bradner W.T., Schurig J.E. Toxicology screening in small animals. Cancer Treat. Rev. 1981, 8:93-102.
6. Chang B., Nishikawa M., Sato E., Utsumi K., Inoue M. l-Carnitine inhibits cisplatin induced injury of the kidney and small intestine. Arch. Biochem. Biophys. 2002, 405:55-64.
7. Cheeseman K.H., Slater T.F. An introduction to free radical biochemistry. Br. Med. Bull. 1993, 49:481-493.
8. Chirino Y.I., Pedraza-Chaverri J. Role of oxidative and nitrosative stress in cisplatin induced nephrotoxicity. Exp. Toxicol. Pathol. 2009, 61:223-242.
9. Cohen S.M., Lippard S.J. Cisplatin: from DNA damage to cancer chemotherapy. Prog. Nucleic Acid Res. Mol. Biol. 2001, 67:93-130.
10. Colliec S., Fischer A.M., Tapon-Bretaudiere J., Boisson C., Durand P., Jozefonvicz J. Anticoagulant properties of a fucoidan fraction. Thromb. Res. 1991, 64:143-154.
11. Comporti M. Lipid peroxidation and cellular damage in toxic liver injury. Lab. Invest. 1985, 53:599-623.
12. Costa L.S., Fidelis G.P., Telles C.B., Dantas-Santos N., Camara R.B., Cordeiro S.L., Costa M.S., Almeida-Lima J., Melo-Silveira R.F., Oliveira R.M., Albuquerque I.R., Andrade G.P., Rocha H.A. Antioxidant and antiproliferative activities of heterofucans from the seaweed Sargassum filipendula. Mar. Drugs 2011, 9:952-966.
13. Dubois M., Gilles K.A., Hamilton J.K., Rebers P.A., Smith F. Colorimetric method for determination of sugars and related substances. Anal. Chem. 1956, 28:350-354.
14. Eglen R.M., Sharif N.A., To Z.P. Muscarinic M3 receptors mediate total inositol phosphates accumulation in murine HSDM1C1 fibrosarcoma cells. Eur. J. Pharmacol. 1993, 244:49-55.
15. Endo T., Takahashi M., Minami M., Yoshioka M., Saito H., Parvez S.H. Effects of anticancer drugs on enzyme activities and serotonin release from ileal tissue in ferrets. Biog. Amines 1993, 9:479-489.
16. Erspamer V.A.D., Testinini A. Observations on the release and turnover rate of 5-hydroxytryptamine in the gastrointestinal tract. J. Pharm. Pharmacol. 1959, 11:618-623.
17. Farndale R.W., Buttle D.J., Barret A.J. Improved quantification and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim. Biophys. Acta 1986, 883:173-177.
18. Fréguin-Bouilland C., Alkhatib B., David N., Lallemand F., Henry J.P., Godin M., Thuillez C., Plissonnier D. Low molecular weight fucoidan prevents neointimal hyperplasia after aortic allografting. Transplantation 2007, 83:1234-1241.
19. 2-induced apoptosis in PC12 cells via activation of PI3K/Akt pathway. Cell Mol. Neurobiol. 2012, 32:523-529.
20. Hafermann M.J., Namdar R., Seibold G.E., Page R.L. Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study. Drug Healthc. Patient Saf. 2011, 3:53-58.
21. Hong S.W., Jung K.H., Lee H.S., Zheng H.M., Choi M.J., Lee C., Hong S.S. Suppression by fucoidan of liver fibrogenesis via the TGF-β/Smad pathway in protecting against oxidative stress. Biosci. Biotechnol. Biochem. 2011, 75:833-840.
22. Khan R., Khan A.Q., Qamar W., Lateef A., Tahir M., Rehman M.U., Ali F., Sultana S. Chrysin protects against cisplatin-induced colon: toxicity via amelioration of oxidative stress and apoptosis: probable role of p38MAPK and p53. Toxicol. Appl. Pharmacol. 2012, 258:315-329.
23. 3 receptors. Br. J. Cancer 1990, 58:651-653.
24. Kim M.H., Joo H.G. Immunostimulatory effects of fucoidan on bone marrow-derived dendritic cells. Immunol. Lett. 2008, 115:138-143.
25. Kim W.J., Koo Y.K., Jung M.K., Moon H.R., Kim S.M., Synytsya A., Yun-Choi H.S., Kim Y.S., Park J.K., Park Y.I. Anticoagulating activities of low-molecular weight fuco-oligosaccharides prepared by enzymatic digestion of fucoidan from the sporophyll of Korean Undaria pinnatifida. Arch. Pharm. Res. 2010, 33:125-131.
26. Kim K.J., Lee O.H., Lee B.Y. Genotoxicity studies on fucoidan from Sporophyll of Undaria pinnatifida. Food Chem. Toxicol. 2010, 48:1101-1104.
27. Kim K.J., Lee O.H., Lee H.H., Lee B.Y. A 4-week repeated oral dose toxicity study of fucoidan from the Sporophyll of Undaria pinnatifida in Sprague-Dawley rats. Toxicology 2010, 267:154-158.
28. 3-receptor antagonist, in rats: inhibition of the distal colonic function. Jpn. J. Pharmacol. 1993, 63:495-502.
29. Ku S.K., Seo B.I., Park J.H., Park G.Y., Seo Y.B., Kim J.S., Lee H.S., Roh S.S. Effect of Lonicerae Flos extracts on reflux esophagitis with antioxidant activity. World J. Gastroenterol. 2009, 15:4799-4805.
30. Kuhn D.M., Vogel R.T., Lovenberg W. Calcium-dependent activation of tryptophan hydroxylase by ATP and magnesium. Biochem. Biophys. Res. Commun. 1978, 82:759-766.
31. Lebwohl D., Canetta R. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur. J. Cancer 1998, 34:1522-1534.
32. Lee H.S., Choi S.H., Ku S.K. Regional distribution and relative frequency of gastrointestinal endocrine cells in the ddN mice: an immunohistochemical study. Anat. Histol. Embryol. 2010, 39:521-528.
33. Levene A. Pathological factors influencing excision of tumours in the head and neck. Part I. Clin. Otolaryngol 1981, 6:145-151.
34. Lowry O.H., Rosebrough N.J., Farr L.A., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
35. Ludbrook J. Update: microcomputer statistics packages. A personal view. Clin. Exp. Pharmacol. Physiol. 1997, 24:294-296.
36. Malik N.M., Liu Y.L., Cole N., Sanger G.J., Andrews P.L. Differential effects of dexamethasone, ondansetron and a tachykinin NK1 receptor antagonist (GR205171) on cisplatin-induced changes in behaviour, food intake, pica and gastric function in rats. Eur. J. Pharmacol. 2007, 555:164-173.
37. Martin C., Roman V., Agay D., Fatôme M. Anti-emetic effect of ondansetron and granisetron after exposure to mixed neutron and gamma irradiation. Radiat. Res. 1998, 149:631-636.
38. McKechnie K., Froese A. Ventricular tachycardia after ondansetron administration in a child with undiagnosed long QT syndrome. Can. J. Anaesth. 2010, 57:453-457.
39. Méité S., Bahi C., Yéo D., Datté J.Y., Djaman J.A., N'guessan D.J. Laxative activities of Mareya micrantha (Benth.) Müll. Arg. (Euphorbiaceae) leaf aqueous extract in rats. BMC Complement. Altern. Med. 2010, 10:7.
40. Minami M., Endo T., Hirafuji M., Hamaue N., Liu Y., Hiroshige T., Memoto M., Saito H., Yoshioka M. Pharmacological aspects of anti-cancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity. Pharmacol. Ther. 2003, 99:149-165.
41. Morais T.C., Pinto N.B., Carvalho K.M., Rios J.B., Ricardo N.M., Trevisan M.T., Rao V.S., Santos F.A. Protective effect of anacardic acids from cashew (Anacardium occidentale) on ethanol-induced gastric damage in mice. Chem. Biol. Interact. 2010, 183:264-269.
42. Odabasoglu F., Cakir A., Suleyman H., Aslan A., Bayir Y., Halici M., Kazaz C. Gastroprotective and antioxidant effects of usnic acid on indomethacin-induced gastric ulcer in rats. J. Ethnopharmacol. 2006, 103:59-65.
43. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
44. Ozmen I., Küfrevioglu O.I. Effects of antiemetic drugs on glucose 6-phosphate dehydrogenase and some antioxidant enzymes. Pharmacol. Res. 2004, 50:499-504.
45. Park H.Y., Han M.H., Park C., Jin C.Y., Kim G.Y., Choi I.W., Kim N.D., Nam T.J., Kwon T.K., Choi Y.H. Anti-inflammatory effects of fucoidan through inhibition of NF-κB, MAPK and Akt activation in lipopolysaccharide-induced BV2 microglia cells. Food Chem. Toxicol. 2011, 49:1745-1752.
46. Park S.Y., Ku S.K., Lee E.S., Kim J.A. 1,3-Diphenylpropenone ameliorates TNBS-induced rat colitis through suppression of NF-κB activation and IL-8 induction. Chem. Biol. Interact. 2012, 196:39-49.
47. Racké K., Schwörer H. Regulation of serotonin release from the intestinal mucosa. Pharmacol. Res. 1991, 23:13-25.
48. Raghavendran H.R., Srinivasan P., Rekha S. Immunomodulatory activity of fucoidan against aspirin-induced gastric mucosal damage in rats. Int. Immunopharmacol. 2011, 11:157-163.
49. Roos I.A., Fairlie D.P., Whitehouse M.W. A peculiar toxicity manifested by platinum(II)amines in rats: gastric distension after intraperitoneal administration. Chem. Biol. Interact. 1981, 35:111-117.
50. Sagar L., Sehgal R., Ojha S. Evaluation of antimotility effect of Lantana camara L. var. acuelata constituents on neostigmine induced gastrointestinal transit in mice. BMC Complement. Altern. Med. 2005, 5:18.
51. Sassi G., Striano B., Merlo U.A. A reporting system for the assessment of chemotherapy toxicity. J. Oncol. Pharm. Pract. 2005, 2005(11):63-67.
52. Saura J., Kettler R., Da Prada M., Richards J.G. Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain. J. Neurosci. 1992, 12:1977-1999.
53. 3 antagonist ondansetron. Anesthesiology 1993, 78:15-20.
54. Sedlak J., Lindsay R.H. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. 1968, 25:192-205.
55. Senni K., Gueniche F., Foucault-Bertaud A., Igondjo-Tchen S., Fioretti F., Colliec-Jouault S., Durand P., Guezennec J., Godeau G., Letourneur D. Fucoidan a sulfated polysaccharide from brown algae is a potent modulator of connective tissue proteolysis. Arch. Biochem. Biophys. 2006, 445:56-64.
56. Sharma S.S., Gupta Y.K. Reversal of cisplatin-induced delay in gastric emptying in rats by ginger (Zingiber officinale). J Ethnopharmacol. 1998, 62:49-55.
57. Shimizu J., Wada-Funada U., Mano H., Matahira Y., Kawaguchi M., Wada M. Proportion of murine cytotoxic T cells is increased by high molecular-weight fucoidan extracted from Okinawa mozuku (Cladosiphon okamuranus). J. Health Sci. 2005, 51:394-397.
58. Song M.Y., Ku S.K., Han J.S. Genotoxicity testing of low molecular weight fucoidan from brown seaweeds. Food Chem. Toxicol. 2012, 50:790-796.
59. Suddek G.M., El-Kenawi A.E., Abdel-Aziz A., El-Kashef H.A. Celecoxib, a selective cyclooxygenase-2 inhibitor, attenuates renal injury in a rat model of Cisplatin-induced nephrotoxicity. Chemotherapy 2011, 57:321-326.
60. Süleyman H., Cadirci E., Albayrak A., Polat B., Halici Z., Koc F., Hacimuftuoglu A., Bayir Y. Comparative study on the gastroprotective potential of some antidepressants in indomethacin-induced ulcer in rats. Chem. Biol. Interact. 2009, 180:318-324.
61. Sun Y., Larry W.O., Ying L. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 1988, 34:497-500.
62. 3 receptor antagonists. Therapie (Paris) 1991, 46:431-435.
63. Vera G., Chiarlone A., Cabezos P.A., Pascual D., Martín M.I., Abalo R. WIN 55,212-2 prevents mechanical allodynia but not alterations in feeding behaviour induced by chronic cisplatin in the rat. Life Sci. 2007, 81:468-479.
64. Visnovsky P. The effect of cyclophosphamide and methotrexate on gastric emptying and secretion in rats. Bratisl. Lek. Listy. 1992, 93:90-92.
65. Wada P.R., Chen J., Jaffe B., Kassem I.S., Blakely R.D., Gershon M.D. Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract. J. Neurosci. 1996, 16:2352-2364.
66. Wang Y., Aggarwal S.K. Effects of cisplatin and taxol on inducible nitric oxide synthase, gastrin and somatostatin in gastrointestinal toxicity. Anticancer Drugs 1997, 8:853-858.
67. Wang Y., Aggarwal S.K., Kopachik W. Role of vitamin d on the inhibition of gastrin production after cisplatin treatment. Met. Based Drugs 2000, 7:115-119.
68. Wang J., Zhang Q., Zhang Z., Song H., Li P. Potential antioxidant and anticoagulant capacity of low molecular weight fucoidan fractions extracted from Laminaria japonica. Int. J. Biol. Macromol. 2010, 46:6-12.
69. Wang J., Wang F., Yun H., Zhang H., Zhang Q. Effect and mechanism of fucoidan derivatives from Laminaria japonica in experimental adenine-induced chronic kidney disease. J. Ethnopharmacol. 2012, 139:807-813.
70. Wintola O.A., Sunmonu T.O., Afolayan A.J. The effect of Aloe ferox Mill. in the treatment of loperamide-induced constipation in Wistar rats. BMC Gastroenterol. 2010, 10:95.
71. Yoshida N., Omoya H., Ito T. DAT-582, a novel serotonin3 receptor antagonist, is a potent and long-lasting antiemetic agent in the ferret and dog. J. Pharmacol. Exp. Ther. 1992, 260:1159-1165.
72. Yu P.L., Fujimura M., Okuyama K., Kinoshita M., Hasegawa H., Fujimiya M. Immunohistochemical localization of tryptophan hydroxylase in the human and rat gastrointestinal tracts. J. Comp. Neurol. 1999, 411:654-665.